An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT03950232 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03950232
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-05
- Primary completion
- 2029-06-19
- Enrollment
- 896
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.